Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

cardiac markers

Known as: cardiac marker 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Comparative analysis of biochemical parameters in diabetic and non-diabetic acute myocardial infarction patients.
BACKGROUND Diabetes is a metabolic disorder characterized by enhanced production of free radicals hence oxidative stress. The aim… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
2015
2015
A sensitive capacitive immunosensor for direct detection of human heart fatty acid-binding protein (h-FABP).
The fabrication of a capacitive interdigitated immunosensor (CID) based on a mixed self-assembled monolayer (mSAM) film for the… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Highly Cited
2015
Highly Cited
2015
Graphene-CNT nanohybrid aptasensor for label free detection of cardiac biomarker myoglobin.
We report a label free electrochemical detection of cardiac bio-marker myoglobin (Mb) on aptamer functionalized rGO/CNT… Expand
2015
2015
Vanillic acid prevents altered ion pumps, ions, inhibits Fas-receptor and caspase mediated apoptosis-signaling pathway and cardiomyocyte death in myocardial infarcted rats.
The present study aims to evaluate the preventive effects of vanillic acid on altered ion pumps, ions and Fas-receptor and… Expand
  • table 2
  • figure 1
  • figure 2
  • figure 4
  • figure 3
2014
2014
Biofunctionalized rebar graphene (f-RG) for label-free detection of cardiac marker troponin I.
One-step microwave-assisted unscrolling of carbon nanotubes to form functionalized rebar graphene (f-RG) is reported. The well… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2014
2014
Elevated Cardiac Markers in Chronic Kidney Disease as a Consequence of Hyperphosphatemia-Induced Cardiac Myocyte Injury
Background Elevated cardiac markers (CMs) and hyperphosphatemia are commonly encountered in patients with chronic kidney diseases… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Review
2014
Review
2014
Cardiac markers following cardiac surgery and percutaneous coronary intervention.
Differentiation between procedure-related necrosis and postprocedural myocardial infarction (MI) is challenging because of the… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Review
2014
Review
2014
The benefits of a rapid, point-of-care "TnI-Only" zero and 2-hour protocol for the evaluation of chest pain patients in the Emergency Department.
  • K. Blick
  • Clinics in laboratory medicine
  • 2014
    • Corpus ID: 206814197
Delays in diagnosis and treatment of cardiac patients presenting in the Emergency Department with symptoms of acute coronary… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
2013
2013
β-Adrenoreceptor Agonist Isoproterenol Alters Oxidative Status, Inflammatory Signaling, Injury Markers and Apoptotic Cell Death in Myocardium of Rats
Sustained high levels of circulating catecholamines are reported to induce cardiotoxicity. Isoproterenol (ISP), a synthetic… Expand
  • figure 1
  • figure 2
  • figure 5
  • figure 6
  • figure 8
2010
2010
Heart-Type Fatty Acid-Binding Protein in the Early Diagnosis of Acute Myocardial Infarction: The potential for influencing patient management.
  • H. Alhadi, K. Fox
  • Sultan Qaboos University medical journal
  • 2010
    • Corpus ID: 20644984
OBJECTIVES The objective of this study was to evaluate the diagnostic value of heart-type fatty acid-binding protein (H-FABP) in… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE